APA (7th ed.) Citation

Nelde, A., Walz, J. S., Kowalewski, D. J., Schuster, H., Wolz, O., Peper, J. K., . . . Weber, A. N. R. (2017). HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy. OncoImmunology, 6(3), N.PAG. https://doi.org/10.1080/2162402X.2016.1219825

Chicago Style (17th ed.) Citation

Nelde, Annika, et al. "HLA Class I-restricted MYD88 L265P-derived Peptides as Specific Targets for Lymphoma Immunotherapy." OncoImmunology 6, no. 3 (2017): N.PAG. https://doi.org/10.1080/2162402X.2016.1219825.

MLA (9th ed.) Citation

Nelde, Annika, et al. "HLA Class I-restricted MYD88 L265P-derived Peptides as Specific Targets for Lymphoma Immunotherapy." OncoImmunology, vol. 6, no. 3, 2017, p. N.PAG, https://doi.org/10.1080/2162402X.2016.1219825.